Automate Your Wheel Strategy on HSIC
With Tiblio's Option Bot, you can configure your own wheel strategy including HSIC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HSIC
- Rev/Share 104.7585
- Book/Share 40.1795
- PB 2.7376
- Debt/Equity 0.9747
- CurrentRatio 1.411
- ROIC 0.0562
- MktCap 9483216202.0
- FreeCF/Share 2.9362
- PFCF 26.4894
- PE 24.2446
- Debt/Assets 0.3079
- DivYield 0
- ROE 0.114
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | HSIC | Barclays | -- | Overweight | -- | $86 | Dec. 9, 2025 |
| Upgrade | HSIC | Evercore ISI | In-line | Outperform | -- | $83 | Aug. 26, 2025 |
| Downgrade | HSIC | Stifel | Buy | Hold | -- | $75 | July 25, 2025 |
| Downgrade | HSIC | Robert W. Baird | Outperform | Neutral | -- | $72 | July 14, 2025 |
| Initiation | HSIC | Wells Fargo | -- | Equal Weight | -- | $80 | Feb. 14, 2025 |
| Upgrade | HSIC | BofA Securities | Underperform | Buy | $69 | $84 | Jan. 6, 2025 |
| Initiation | HSIC | Mizuho | -- | Neutral | -- | $75 | Dec. 4, 2024 |
News
Henry Schein Can Make Your Portfolio Smile
Published: December 05, 2025 by: Seeking Alpha
Sentiment: Positive
Henry Schein stands out as the largest global provider of healthcare products and services for office-based dental and medical practitioners, with a strong market share. HSIC continues to deliver solid growth, reporting Q3 revenue up 5.2% year-over-year and improved profitability across all segments, driven by internal growth and targeted programs. Management anticipates ongoing revenue and EBITDA growth, supported by demographic trends, increased healthcare access, and technological advancements like AI in dental care.
Read More
Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report?
Published: December 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Read More
Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Published: December 02, 2025 by: Seeking Alpha
Sentiment: Neutral
Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Read More
HSIC Stock Benefits From Expanded Partnership With vVARDIS
Published: December 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.
Read More
Henry Schein, Inc. (HSIC) Presents at Jefferies London Healthcare Conference 2025 Transcript
Published: November 18, 2025 by: Seeking Alpha
Sentiment: Neutral
Henry Schein, Inc. ( HSIC ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Stanley Bergman - Executive Chairman & CEO Andrea Albertini - Chief Executive Officer of Global Distribution & Technology Graham Stanley - VP of Investor Relations & Strategic Finance Project Officer Conference Call Participants Michael Sarcone - Jefferies LLC, Research Division Presentation Michael Sarcone Jefferies LLC, Research Division Hi, everyone. My name is Mike Sarcone.
Read More
Henry Schein, Inc. (HSIC) Presents at Stifel 2025 Healthcare Conference Transcript
Published: November 12, 2025 by: Seeking Alpha
Sentiment: Neutral
Henry Schein, Inc. ( HSIC ) Stifel 2025 Healthcare Conference November 12, 2025 11:20 AM EST Company Participants Andrea Albertini - Chief Executive Officer of Global Distribution & Technology Tom Popeck - Chief Executive Officer of Henry Schein Products Group Ronald South - Senior VP & CFO Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Jonathan Block Stifel, Nicolaus & Company, Incorporated, Research Division I'm happy to introduce the team from Henry Schein. We have Ron South, CFO; Andrea Albertini, CEO of Global Distribution and Technology; and Tom Popeck, CEO of the Henry Schein …
Read More
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Henry Schein (HSIC) is a Strong Growth Stock
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Henry Schein, Inc. (HSIC) Q3 2025 Earnings Call Transcript
Published: November 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Henry Schein, Inc. ( HSIC ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Graham Stanley - VP of Investor Relations & Strategic Finance Project Officer Stanley Bergman - Executive Chairman & CEO Ronald South - Senior VP & CFO Conference Call Participants Jason Bednar - Piper Sandler & Co., Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division John Stansel - JPMorgan Chase & Co, Research Division Allen Lutz - BofA Securities, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, …
Read More
Here's What Key Metrics Tell Us About Henry Schein (HSIC) Q3 Earnings
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Henry Schein's Q3 earnings and revenues top estimates, lifting the stock as the company raised its 2025 outlook on solid business momentum.
Read More
Here's How Henry Schein Is Placed Ahead of Q3 Earnings
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
HSIC heads into Q3 with solid gains expected across Dental, Specialty and Tech segments, though earnings estimates have slipped slightly.
Read More
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2025 financial results before the stock market opens on Tuesday, November 4, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Bo.
Read More
The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide
Published: October 15, 2025 by: PRNewsWire
Sentiment: Neutral
CHICAGO , Oct. 15, 2025 /PRNewswire/ -- The Aspen Group (TAG), one of the largest and fastest-growing retail healthcare business support organizations in the U.S., today announced a new partnership with Planmeca to bring advanced digital imaging technology to Aspen Dental locations nationwide. Following a rigorous evaluation process, Planmecas Viso® and ProMax® CBCT imaging units were selected, along with Planmeca ProX™, ProSensor® HD, and ProX™ GO 2D intraoral imaging systems, to be integrated across Aspen Dental's network of more than 1,100 locations.
Read More
Henry Schein, Inc. (HSIC) Presents At Baird Global Healthcare Conference 2025 Transcript
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Neutral
Henry Schein, Inc. (NASDAQ:HSIC ) Baird Global Healthcare Conference 2025 September 10, 2025 10:50 AM EDT Company Participants Stanley Bergman - Executive Chairman & CEO Andrea Albertini - Chief Executive Officer of Global Distribution & Technology Tom Popeck - Chief Executive Officer of Henry Schein Products Group Ronald South - Senior VP & CFO Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Presentation Jeffrey Johnson Senior Research Analyst All right.
Read More
Henry Schein Medical Expands SolutionsHub with Colaborate
Published: September 09, 2025 by: PRNewsWire
Sentiment: Neutral
Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories.
Read More
Worldpay & Henry Schein One: Exclusive Partnership Powers Dental Practices
Published: August 27, 2025 by: Business Wire
Sentiment: Neutral
CINCINNATI--(BUSINESS WIRE)--Today, Worldpay® announced it will continue as the exclusive provider of embedded payments for Henry Schein One in a long-term agreement. Since 2004, Worldpay has been the trusted payments partner to Henry Schein One, North America's leading dental software provider serving more than 75,000 practices. This partnership has elevated Henry Schein One's payments business into a powerful driver of revenue and growth while enhancing the experience for its clients and thei.
Read More
Henry Schein to Participate in Upcoming Investor Conferences in September
Published: August 22, 2025 by: Business Wire
Sentiment: Neutral
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Wells Fargo Healthcare Conference at the Encore Boston hotel, Boston, MA, on September 4, 2025, at 11:00 a.m. EST. Baird Global Healthcare Conference at the InterContinental hotel, New York City, on September 10, 2025, at 10:50 a.m. EST. Bank o.
Read More
Henry Schein: The Case For An Upgrade From Hold To Buy
Published: August 14, 2025 by: Seeking Alpha
Sentiment: Positive
Henry Schein is transitioning to higher-margin businesses, with strong tailwinds in dental and medical markets, and is now fairly valued after previous overvaluation. KKR's strategic investment and restructuring support, plus resolution of past issues like the cyber incident, position HSIC for margin improvement and renewed growth. Despite recent stagnation, margin compression, and tariff headwinds, management is actively addressing challenges through efficiency initiatives and product mix shifts.
Read More
Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Negative
HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.
Read More
Henry Schein: Still Bullish Even As Shares Languish
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Positive
Henry Schein remains a "Buy" as its valuation is attractive relative to peers, despite recent underperformance versus the S&P 500. Financial results have been mixed, but management's 2025 guidance suggests revenue and earnings growth are likely ahead. Ongoing acquisitions and a strategic $250 million investment from KKR support long-term growth and capital allocation flexibility.
Read More
Henry Schein to Report Q2 Earnings: What's in Store for the Stock?
Published: July 29, 2025 by: Zacks Investment Research
Sentiment: Positive
HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.
Read More
IntelePeer Joins Henry Schein One Academic Partner Program
Published: July 17, 2025 by: Business Wire
Sentiment: Neutral
DANIA BEACH, Fla.--(BUSINESS WIRE)--IntelePeer, a leading, end-to-end conversational AI platform provider for Dental Service Organizations (DSOs), today announced that it is now an authorized integration vendor in the Henry Schein One Academic Partner Program. With this integration, dental academic clinic teams can now easily use IntelePeer to implement AI voice agents and call centers within their clinical workflows to optimize scheduling and help prevent missed patient calls, augment front of.
Read More
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Published: July 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.
Read More
Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Henry Schein (HSIC) is a Strong Value Stock
Published: June 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Henry Schein (HSIC) is a Strong Growth Stock
Published: June 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
About Henry Schein, Inc. (HSIC)
- IPO Date 1995-11-03
- Website https://www.henryschein.com
- Industry Medical - Distribution
- CEO Stanley Bergman
- Employees 25000